Buscar

Mostrando ítems 1-5 de 5

Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults.

Moreira Júnior, Edson Duarte; Palefsky, Joel M; Giuliano, Anna R; Goldstone, Stephen; Aranda, Carlos; Jessen, Heiko; Hillman, Richard J; Ferris, Daron G; Coutlee, Francois; Vardas, Eftyhia; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M; Guris, Dalya; Garner, Elizabeth I. O (Taylor & Francis, 2014)

Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.

Hillman, Richard J; Giuliano, Anna R; Palefsky, Joel M; Goldstone, Stephen; Moreira Júnior, Edson Duarte; Vardas, Eftyhia; Aranda, Carlos; Jessen, Heiko; Ferris, Daron G; Coutlee, Francois; Marshall, J. Brooke; Vuocolo, Scott; Haupt, Richard M; Guris, Dalya; Garner, Elizabeth I. O (American Society for Microbiology, 2014)

Phase III, randomized controlled trial in girls 9-15 years old to evaluate lot consistency of a novel nine-valent human papillomavirus L1 virus-like particle vaccine.

Luxembourg, Alain; Moreira Junior, Edson Duarte; Samakoses, Rudiwilai; Kim, Kyung-Hyo; Sun, Xiao; Maansson, Roger; Moeller, Erin; Christiano, Susan; Chen, Joshua (Taylor & Francis: STM, Behavioural Science and Public Health Titles, 2016)

Efeito da vacina contra papilomavírus humano (tipos 6, 11, 16 e 18) no tratamento de crianças com papilomatose respiratória recorrente

Hermann, Juliana Sato [UNIFESP] (Universidade Federal de São Paulo (UNIFESP), 2015-12-16)

Purpose: To evaluate whether the tetravalent vaccine against human papilomavírus (HPV) (types 6, 11, 16 and 18), when administered in a group of patients with juvenile-onset recurrent respiratory papillomatosis (RRP), ...

Educação em saúde : conhecimento sobre o câncer do colo do útero na perspectiva de alunas do ensino médio em Aracaju – SE

Bispo, Margarida Ferreira (DBI - Departamento de Biologia – São Cristóvão – PresencialUniversidade Federal de Sergipe, 2018)